|
ATE437870T1
(de)
|
2004-05-12 |
2009-08-15 |
Pfizer Prod Inc |
Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
|
|
CN101193852A
(zh)
*
|
2005-02-18 |
2008-06-04 |
因诺迪亚有限公司 |
4-羟基异亮氨酸类似物及其用途
|
|
WO2006131836A2
(en)
*
|
2005-03-22 |
2006-12-14 |
Innodia Inc. |
Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
|
|
WO2006116157A2
(en)
|
2005-04-22 |
2006-11-02 |
Alantos Pharmaceuticals Holding, Inc. |
Dipeptidyl peptidase-iv inhibitors
|
|
JP2009504599A
(ja)
*
|
2005-08-11 |
2009-02-05 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｄｐｐ−ｉｖ阻害剤を含有する医薬組成物
|
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
|
WO2007107008A1
(en)
*
|
2006-03-22 |
2007-09-27 |
Innodia Inc. |
Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
GB0713602D0
(en)
*
|
2007-07-12 |
2007-08-22 |
Syngenta Participations Ag |
Chemical compounds
|
|
WO2009037719A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Lupin Limited |
Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
|
|
JP5305704B2
(ja)
*
|
2008-03-24 |
2013-10-02 |
富士フイルム株式会社 |
新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
|
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
|
US8748457B2
(en)
|
2009-06-18 |
2014-06-10 |
Lupin Limited |
2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors
|
|
US8999975B2
(en)
*
|
2011-09-19 |
2015-04-07 |
Boehringer Ingelheim International Gmbh |
Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
|
|
MD4841B1
(ro)
|
2012-12-21 |
2023-01-31 |
Gilead Sciences, Inc. |
Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică
|
|
ES2845473T3
(es)
|
2013-03-14 |
2021-07-26 |
Boehringer Ingelheim Int |
(Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C
|
|
US8877775B2
(en)
|
2013-03-14 |
2014-11-04 |
Boehringer Ingelheim International Gmbh |
Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
|
|
NO2865735T3
(US06894165-20050517-C00155.png)
|
2013-07-12 |
2018-07-21 |
|
|
|
EP3252058B1
(en)
|
2013-07-12 |
2021-01-20 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
|
|
NO2717902T3
(US06894165-20050517-C00155.png)
|
2014-06-20 |
2018-06-23 |
|
|
|
TWI744723B
(zh)
|
2014-06-20 |
2021-11-01 |
美商基利科學股份有限公司 |
多環型胺甲醯基吡啶酮化合物之合成
|
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
|
JP6529575B2
(ja)
|
2014-08-01 |
2019-06-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換オキセタンおよびそれらのカテプシンｃの阻害薬としての使用
|
|
WO2016038007A1
(en)
|
2014-09-12 |
2016-03-17 |
Boehringer Ingelheim International Gmbh |
Spirocyclic inhibitors of cathepsin c
|
|
TWI738321B
(zh)
|
2014-12-23 |
2021-09-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
|
EA201791982A1
(ru)
|
2015-03-09 |
2020-02-17 |
Интекрин Терапьютикс, Инк. |
Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
|
|
SG11201707905WA
(en)
|
2015-04-02 |
2017-10-30 |
Gilead Sciences Inc |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
|
EP3606527A1
(en)
|
2017-04-03 |
2020-02-12 |
Coherus Biosciences, Inc. |
Ppar-gamma agonist for treatment of progressive supranuclear palsy
|
|
IT201700059292A1
(it)
*
|
2017-05-31 |
2018-12-01 |
Univ Pisa |
Derivati 1,3-diaza-4-ossa-[3.3.1]-biciclici, loro preparazione e uso come medicinale, in particolare per il trattamento del diabete
|
|
CN112771055B
(zh)
|
2018-08-08 |
2023-10-20 |
住友制药株式会社 |
光学活性桥接哌啶衍生物
|
|
BR112021002090A8
(pt)
|
2018-08-27 |
2022-12-06 |
Sumitomo Dainippon Pharma Co Ltd |
Derivado azabicíclico opticamente ativo
|
